0.1479
-0.0071
(-4.58%)
At close: January 10 at 8:07:46 AM GMT+1
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Cash Flow
-18,896.3130
-18,896.3130
-30,339.1170
-14,421.3980
-6,843.7440
Investing Cash Flow
11,119.3040
11,119.3040
34,781.4370
-46,341.3120
-228.7770
Financing Cash Flow
5,067.4480
5,067.4480
503.4610
36,664.5660
30,997.3070
End Cash Position
6,012.2740
6,012.2740
8,721.8350
3,776.0540
27,874.1980
Capital Expenditure
--
--
-99.2590
-329.0000
-17.2290
Issuance of Capital Stock
4,959.5060
4,959.5060
--
20,279.1780
21,126.1040
Repayment of Debt
-169.2300
-169.2300
-171.9310
-168.5600
-28.0000
Free Cash Flow
-18,896.3130
-18,896.3130
-30,438.3760
-14,750.3980
-6,860.9730
10/31/2021 - 3/11/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACW.AX Actinogen Medical Limited
0.0250
0.00%
BVNKF Bavarian Nordic A/S
26.25
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0200
0.00%
AKTX Akari Therapeutics, Plc
1.2150
-5.08%
DXB.AX Dimerix Limited
0.5050
+6.32%
MDNAF Medicenna Therapeutics Corp.
0.9500
-3.06%
PBLA Panbela Therapeutics, Inc.
0.3700
+2.49%
ATXI Avenue Therapeutics, Inc.
1.8114
-4.16%
ADIL Adial Pharmaceuticals, Inc.
1.0200
-0.97%
INKT MiNK Therapeutics, Inc.
0.7310
-6.05%